NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 143 filers reported holding NEOGENOMICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $414,823 | -11.8% | 29,908 | 0.0% | 0.02% | -11.8% |
Q1 2024 | $470,153 | -3.2% | 29,908 | -0.4% | 0.02% | -15.0% |
Q4 2023 | $485,675 | +33.1% | 30,017 | +1.2% | 0.02% | +25.0% |
Q3 2023 | $364,904 | -23.5% | 29,667 | 0.0% | 0.02% | -20.0% |
Q2 2023 | $476,748 | -7.7% | 29,667 | 0.0% | 0.02% | -9.1% |
Q1 2023 | $516,502 | +87.3% | 29,667 | -0.6% | 0.02% | +83.3% |
Q4 2022 | $275,749 | +8.6% | 29,843 | +1.0% | 0.01% | 0.0% |
Q3 2022 | $254,000 | +5.4% | 29,558 | 0.0% | 0.01% | +9.1% |
Q2 2022 | $241,000 | -33.4% | 29,558 | -0.8% | 0.01% | -21.4% |
Q1 2022 | $362,000 | -64.4% | 29,808 | 0.0% | 0.01% | -63.2% |
Q4 2021 | $1,017,000 | -29.3% | 29,808 | 0.0% | 0.04% | -37.7% |
Q3 2021 | $1,438,000 | +6.8% | 29,808 | 0.0% | 0.06% | +10.9% |
Q2 2021 | $1,346,000 | -6.4% | 29,808 | 0.0% | 0.06% | -9.8% |
Q1 2021 | $1,438,000 | -10.4% | 29,808 | 0.0% | 0.06% | -15.3% |
Q4 2020 | $1,605,000 | +48.5% | 29,808 | +1.7% | 0.07% | +38.5% |
Q3 2020 | $1,081,000 | +19.1% | 29,308 | 0.0% | 0.05% | +4.0% |
Q2 2020 | $908,000 | +12.2% | 29,308 | 0.0% | 0.05% | -2.0% |
Q1 2020 | $809,000 | -5.6% | 29,308 | 0.0% | 0.05% | +18.6% |
Q4 2019 | $857,000 | +55.3% | 29,308 | +1.6% | 0.04% | +48.3% |
Q3 2019 | $552,000 | -12.8% | 28,858 | 0.0% | 0.03% | -17.1% |
Q2 2019 | $633,000 | +7.3% | 28,858 | 0.0% | 0.04% | +2.9% |
Q1 2019 | $590,000 | +63.9% | 28,858 | +1.1% | 0.03% | +41.7% |
Q4 2018 | $360,000 | -17.8% | 28,558 | 0.0% | 0.02% | -11.1% |
Q3 2018 | $438,000 | -91.2% | 28,558 | -92.5% | 0.03% | -91.0% |
Q2 2018 | $4,963,000 | +60.7% | 378,558 | 0.0% | 0.30% | +52.8% |
Q1 2018 | $3,089,000 | -7.9% | 378,558 | 0.0% | 0.20% | -7.5% |
Q4 2017 | $3,354,000 | -25.3% | 378,558 | -6.2% | 0.21% | -29.0% |
Q3 2017 | $4,492,000 | +24.2% | 403,558 | 0.0% | 0.30% | +15.4% |
Q2 2017 | $3,616,000 | +197.9% | 403,558 | +162.4% | 0.26% | +192.1% |
Q1 2017 | $1,214,000 | -7.9% | 153,808 | 0.0% | 0.09% | -16.0% |
Q4 2016 | $1,318,000 | +4.3% | 153,808 | 0.0% | 0.11% | -21.5% |
Q3 2016 | $1,264,000 | -21.5% | 153,808 | -23.2% | 0.14% | -24.6% |
Q2 2016 | $1,610,000 | +19.3% | 200,250 | 0.0% | 0.18% | +12.6% |
Q1 2016 | $1,350,000 | -14.3% | 200,250 | 0.0% | 0.16% | -15.4% |
Q4 2015 | $1,576,000 | +37.4% | 200,250 | 0.0% | 0.19% | +21.3% |
Q3 2015 | $1,147,000 | +5.9% | 200,250 | 0.0% | 0.16% | +9.9% |
Q2 2015 | $1,083,000 | +15.8% | 200,250 | 0.0% | 0.14% | +11.0% |
Q1 2015 | $935,000 | +12.0% | 200,250 | 0.0% | 0.13% | +3.3% |
Q4 2014 | $835,000 | -19.9% | 200,250 | 0.0% | 0.12% | -26.3% |
Q3 2014 | $1,043,000 | +49.4% | 200,250 | -4.8% | 0.17% | +41.5% |
Q2 2014 | $698,000 | +0.4% | 210,250 | +5.0% | 0.12% | -9.2% |
Q1 2014 | $695,000 | -4.1% | 200,250 | 0.0% | 0.13% | -13.3% |
Q4 2013 | $725,000 | +20.6% | 200,250 | 0.0% | 0.15% | +0.7% |
Q3 2013 | $601,000 | -24.6% | 200,250 | 0.0% | 0.15% | -37.9% |
Q2 2013 | $797,000 | – | 200,250 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |